Identification of this histologically unusual tumor as a NUTM1 fusion thyroid carcinoma required recognition of the histology as unusual, perfoming a panel of IHC antibody stains, and following up initial negative genetic test results with extended molecular genetic testing. The gene discussed is NUTM1; the disease is thyroid gland carcinoma.